Nanomedicine News

RSS

Student Nanomedicine Researchers Named National Finalists in Siemens Math, Science & Technology Competition

Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for three students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition for high school students.

11 Nov 2013

Alnylam Reports Positive Results from Tekmira LNP Technology-Enabled Patisiran Clinical Trial

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today reported that Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY) presented positive results from its Phase II clinical trial with patisiran (ALN-TTR02), an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR), which is enabled by Tekmira's lipid nanoparticle (LNP) technology. The program represents the most clinically advanced application of Tekmira's proprietary LNP delivery technology.

11 Nov 2013

Panacea Presents Papers on Nanoparticle-Based Therapeutic Cancer Vaccine at SITC Annual Meeting

Panacea Pharmaceuticals, Inc. presents three papers regarding its Nanoparticle-Based Therapeutic Cancer Vaccine at the Society for Immunotherapy of Cancer Annual Meeting at National Harbor, MD held November 8-10, 2013.

11 Nov 2013

Leading Research Institutes and Charitable Foundations Contract with imec for Neuroscience Research

Nanoelectronics research center imec announced today that the Howard Hughes Medical Institute (HHMI), the Allen Institute for Brain Science, the Gatsby Charitable Foundation, the Wellcome Trust, and University College London (UCL) have committed 4.2 million Euro ($5.5 million) in R&D collaboration contracting with imec to develop and manufacture a state-of-the-art sensor array for recording neural activity in animal brains.

From IMEC 8 Nov 2013

Researchers Report Nanoparticles Filled with Chemotherapeutic Drugs Can Destroy Breast Cancer

Nanoparticles filled with chemotherapeutic drugs can kill drug-resistant breast cancer cells, according to a study published in the scientific journal Biomaterials.

8 Nov 2013

Engineering Tetrapod Quantum Dots to Improve Diagnostic Accuracy of Biomedical Assays and Devices for Quantum Materials Corp.

Quantum Materials Corp. announced today that it has provided Tetrapod Quantum Dots (TQD) to an advanced medical device manufacturer to optimize performance of an “engineered spectrum” quantum dot-enabled ligh...

From QM Cell Dots 7 Nov 2013

UltraSM® Membranes for Chip-Sized Diagnostics from SiMPore

A groundbreaking collaboration between researchers at SiMPore Inc., the University of Rochester and the Rochester Institute of Technology has led to the development of a highly efficient automated chip-sized pump.

From SiMPore Inc. 7 Nov 2013

Midatech to Advance Biocompatible Gold-Nanoparticle Technology for Nano-Medical Applications through New Funding

Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on its unique biocompatible gold-nanoparticles (GNP), is pleased to announce that is has successfully raised £10 million through the issue of new equity. The investment round was led by Ippon Capital SA, a Geneva-based private equity firm, which committed £7.6 million with the remainder coming from existing investors.

6 Nov 2013

Biological Chemotherapy Nanoparticle Developer Donates $4 M to UC Global Health Institute

The Chan Soon-Shiong Family Foundation has donated $4 million to the University of California Global Health Institute to support new cross-campus and interdisciplinary education and research programs that aim to improve the health and well-being of vulnerable people and communities throughout California and across the globe.

From University of California, Los Angeles 5 Nov 2013

NanoViricides Renews Evaluation Contract with Dr. Harris’ Lab for DengueCide

NanoViricides, Inc. (the "Company"), announced today that theDengueCide evaluation contract has been renewed with Dr. Eva Harris’ Laboratory at the University of California, Berkeley, School of Public Health, Division of Infectious Diseases and Vaccinology.

From NanoViricides, Inc 5 Nov 2013

Nanomedicine News

Student Nanomedicine Researchers Named National Finalists in Siemens Math, Science & Technology Competition

Alnylam Reports Positive Results from Tekmira LNP Technology-Enabled Patisiran Clinical Trial

Panacea Presents Papers on Nanoparticle-Based Therapeutic Cancer Vaccine at SITC Annual Meeting

Leading Research Institutes and Charitable Foundations Contract with imec for Neuroscience Research

Researchers Report Nanoparticles Filled with Chemotherapeutic Drugs Can Destroy Breast Cancer

Engineering Tetrapod Quantum Dots to Improve Diagnostic Accuracy of Biomedical Assays and Devices for Quantum Materials Corp.

UltraSM® Membranes for Chip-Sized Diagnostics from SiMPore

Midatech to Advance Biocompatible Gold-Nanoparticle Technology for Nano-Medical Applications through New Funding

Biological Chemotherapy Nanoparticle Developer Donates $4 M to UC Global Health Institute

NanoViricides Renews Evaluation Contract with Dr. Harris’ Lab for DengueCide

Laser-Induced Graphene for Printable and Biomedical Applications

Cigarette Waste as a Source for Sustainable Supercapacitors

Co-Solvent-Driven Laser Assembly of Gold Nanorods

Novel Technique Dramatically Increases Graphene's Elasticity

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Breaking Barriers in Thin-Film Deposition with ATLANT 3D’s DALP Technology

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

Sponsored Content

Unlocking Material Behavior at the Microscale Using Nanoindentation

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination